Zhong-Hao Liu

Zhong-Hao Liu

Auto-generated profile, based on publicly available information

Zhong-Hao Liu

Department of Implantology, the affiliated Yantai Stomatological Hospital, Binzhou Medical University, Yantai, Shandong 264001, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2017 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
PDF file
KDKai Dong
Kai Dong
PHPengjie Hao
Pengjie Hao
SXSheng Xu
Sheng Xu
SLShutai Liu
Shutai Liu
WZWenjuan Zhou
Wenjuan Zhou
ZLZhonghao Liu
Zhonghao Liu
Background/Aims: Patients with diabetes mellitus have a higher risk of dental implant failure. One major cause is high-glucose induced oxidative stress. Alpha-lipoic acid (ALA), a naturally occurring compound and dietary supplement, has been established as a potent antioxidant that is a strong scavenger of free radicals. However, few studies have yet investigated the effect of ALA on osteogenic differentiation of osteoblasts cultured with high glucose medium. The aim of this study is to investigate the effects of ALA on the osteoblastic differentiation in MC3T3-E1 cells under high glucose condition. Methods: MC3T3-E1 cells were divided into 4 groups including normal glucose (5.5 mM) group (control), high glucose (25.5 mM) group, high glucose + 0.1 mM ALA group, and high glucose + 0.2 mM ALA group. The proliferation, osteogenic differentiation and mineralization of cells were evaluated by MTT assay, alkaline phosphatase (ALP) activity assay, alizarin red staining and real time-polymerase chain reaction. High-glucose induced oxidative damage was also assessed by the production of reactive oxygen species (ROS) and superoxide dismutase (SOD). Western blots were performed to examine the role of PI3K/Akt pathway. Results: The proliferation, osteogenic differentiation and mineralization of MC3T3-E1 cells were significantly decreased by the ROS induced by high-glucose. All observed oxidative damage and osteogenic dysfunction induced were inhibited by ALA. Moreover, the PI3K/Akt pathway was activated by ALA. Conclusions: We demonstrate that ALA may attenuate high-glucose mediated MC3T3-E1 cells dysfunction through antioxidant effect and modulation of PI3K/Akt pathway.

1 January 2023 in Journal of Periodontal & Implant Science
Verified
Journal Article
Open access
PDF file
KDKai Dong
Kai Dong
WZWenjuan Zhou
Wenjuan Zhou
ZLZhong-Hao Liu
Zhong-Hao Liu
Dong K, et al. J Periodontal Implant Sci. 2022 Aug;52:e30. https://doi.org/10.5051/jpis.2106240312

10 August 2012 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
SLShutai Liu
Shutai Liu
HWHuaizhou Wang
Huaizhou Wang
CQCaiqing Qiu
Caiqing Qiu
JZJing Zhang
Jing Zhang
TZTaowen Zhang
Taowen Zhang
ZLZhonghao Liu
Zhonghao Liu
Periodontitis is a chronic inflammatory disease associated with gram-negative subgingival microflora infection. Accumulating experimental evidence suggests that escin exerts anti-inflammatory and anti-edematous effects. This study was designed to investigate the in vitro effects of escin on the inflammatory reaction of human periodontal ligament cells (hPDLs). hPDLs were stimulated with lipopolysaccharide (LPS). The cells were treated with various concentrations of escin. The viability of hPDLs was evaluated using the MTT method. The expression of Toll-like receptor 2 (TLR2) in hPDLs and the levels of IL-1β, TNF-α and IL-6 in the supernatant were measured. Escin significantly attenuated LPS-induced cytotoxicity in a concentration-dependent manner in hPDLs. Treatment with escin partly blocked the expression of TLR2. Escin also lowered the increase of pro-inflammatory cytokines (IL-1β, TNF-α and IL-6) induced by LPS. The present findings show that escin exerts a protective effect against LPS-induced inflammation in hPDLs. It was also shown that escin is a promising medicine for the treatment of periodontitis.

28 April 2025 in Journal of Dentistry
Verified
Journal Article
Closed access
KDKai Dong
Kai Dong
XLXueying Li
Xueying Li
WZWenjuan Zhou
Wenjuan Zhou
ZLZhong Hao Liu
Zhong Hao Liu

1 May 2013
Verified
Journal Article
Closed access
KDKai Dong
Kai Dong
ZLZhong-Hao Liu
Zhong-Hao Liu
XZXiao-Jie Zhang
Xiao-Jie Zhang
FXFeng-Wei Xu
Feng-Wei Xu
To evaluate the effect of platelet-rich fibrin extract (PRFe) on proliferation and differentiation and F-actin cytoskeleton of osteoblasts. The experimental group used the α-minimum essential medium (α-MEM) containing PRFe (10% fetal bovine serum), and the control group used the α-MEM (10% fetal bovine serum). The number of the osteoblasts at 1st, 3rd, 5th d was detected by methyl thiazolyl tetrazolium (MTT) assay, and the differentiation of osteoblast at 1st, 3rd, 5th,7 th d detected by the activity of alkaline phosphatase (ALP).The alizarin red dye was used to observe the number of calcium nodus at 14th, 21st d. The F-actin cytoskeleton was evaluated by confocal laser scanning microscope(CLSM) at 3rd,6th,9th,12th h. The level of osteogenetic biomarkers osteocalcin (OCN) and core-binding factor α1(Cbfα1) at 3rd,7th d were quantified by real-time PCR. A significant increase of absorbance at 1st, 3rd, 5th d was showed in experimental group (0.336 ± 0.011, 0.571 ± 0.039, 0.787 ± 0.050) compared to control group (0.300 ± 0.021, 0.387 ± 0.040, 0.527 ± 0.034) (P < 0.05). The absorbance of experimental group at 1st, 3rd, 5th, 7th d (0.146 ± 0.014, 0.199 ± 0.017, 0.390 ± 0.020, 0.492 ± 0.019) was significantly higher than that of control group (0.115 ± 0.014, 0.145 ± 0.015, 0.190 ± 0.015, 0.230 ± 0.026) (P < 0.05). The integrated absorbance of the calcium nodus in experimental group at 14th, 21st d (22.119 ± 3.694, 31.528 ± 3.162) was significantly higher than in control group (8.498 ± 2.041, 15.162 ± 2.526) (P < 0.05). The Cbfα1 and OCN gene expression in experimental group was higher than in control group (P < 0.05). PRFe could enhance the proliferation and differentiation of osteoblasts and promote the spread of F-actin cytoskeleton.

1 May 2012
Verified
Journal Article
Closed access
WZWenjuan Zhou
Wenjuan Zhou
ZLZhong-Hao Liu
Zhong-Hao Liu
PHPeng-Jie Hao
Peng-Jie Hao
SXSheng Xu
Sheng Xu
ASAi-Jie Sun
Ai-Jie Sun
ZLZhuo-Rui Li
Zhuo-Rui Li
To observe the expression of receptor activator of NF-κB ligand (RANKL) and its decoy receptor osteoprotegerin (OPG) during unloading period of dental implants. An animal model of dental implants was established in Beagle dogs. Bone remodeling was tested at 3, 7, 15, 30, 60 and 90 days after the placement of implants. RANKL and OPG mRNA expression were quantified by real-time PCR. Then mandibular bones were resected and some sections were observed. The most prominent period of bone remodeling occurred at 7 day after the placement of implants (OPG/RANKL mRNA, 2.15 ± 0.1). The expression of RANKL and OPG increased in a time-dependent manner in both soft and hard tissue. After 7 days they gradually decreased. Both OPG and RANKL were expressed in peri-implant tissues, and the changing tendency of RANKL and OPGmRNA was consistent with the change of bone remodeling. The active stage for bone remodelling in peri-implant tissues during unloading period is about 7 days after implantation.